Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 29 May 2021 |
2 | Reply to Exam Report (MIS-R) | 24 Jul 2021 |
3 | Authorization Letter | 30 Nov 2023 |
4 | Journal Copy | 04 Mar 2024 |
5 | TM-O(NOTICE OF OPPOSITION) | 13 Apr 2024 |
6 | Annexure -1 under rule 46 | 17 Dec 2024 |
7 | Evidence Affidavit Under Rule 46 (TOP) | 17 Dec 2024 |
1 | EXAMINATION REPORT | 11761292 | 03 Jul 2021 | |
2 | Hearing Notice (Show Cause) | 16439096 | 03 Nov 2023 | |
3 | Tribunal Accepted Notice for : 4988199 | 16738883 | 6373399 | 06 Dec 2023 |
4 | Opposition Notice | 18297906 | 6759949 | 11 Jun 2024 |
5 | Opposition Counter Statement | 18828627 | 6902657 | 10 Sep 2024 |
As per IP India data the trademark was applied on 29 May 2021.
MAXIMON PHARMA applied for Relisol d3.
Listed class of trademark Relisol d3 is 5.
Relisol d3 is on the Opposed stage of the trademark process.
Serial Number provided to trademark application is 4988199
Trademark application was filed by the following attorney agent:
Legus Intellect
The trademark is categorized as WORD.